Cargando…

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers

BACKGROUND: Lysergic acid diethylamide (LSD) is an ergot alkaloid derivative with psychedelic properties that has been implicated in the management of persistent pain. Clinical studies in the 1960s and 1970s have demonstrated profound analgesic effects of full doses of LSD in terminally ill patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramaekers, Johannes G, Hutten, Nadia, Mason, Natasha L, Dolder, Patrick, Theunissen, Eef L, Holze, Friederike, Liechti, Matthias E, Feilding, Amanda, Kuypers, Kim PC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054163/ https://www.ncbi.nlm.nih.gov/pubmed/32842825 http://dx.doi.org/10.1177/0269881120940937

Ejemplares similares

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
por: Holze, Friederike, et al.
Publicado: (2020)

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers
por: Hutten, Nadia R. P. W., et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects
por: Dolder, Patrick C., et al.
Publicado: (2017)

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2020)

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity
por: Bedford, Peter, et al.
Publicado: (2023)

Lysergic Acid Diethylamide and Mescaline in Experimental Psychiatry
por: Freedman, Daniel X.
Publicado: (1957)

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2022)

Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
por: Kopra, Emma I, et al.
Publicado: (2023)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers
por: Family, Neiloufar, et al.
Publicado: (2019)

Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans
por: Kanen, Jonathan W., et al.
Publicado: (2023)

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
por: Ley, Laura, et al.
Publicado: (2023)

Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review
por: Więckiewicz, Gniewko, et al.
Publicado: (2021)

Lysergic acid diethylamide induces increased signalling entropy in rats’ prefrontal cortex
por: Savino, Aurora, et al.
Publicado: (2021)

Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies
por: Kuypers, Kim PC, et al.
Publicado: (2017)

Neurocognition and Subjective Experience Following Acute Doses of the Synthetic Cannabinoid JWH-018: Responders Versus Nonresponders
por: Theunissen, Eef L., et al.
Publicado: (2019)

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology
por: De Gregorio, Danilo, et al.
Publicado: (2016)

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
por: Gasser, Peter, et al.
Publicado: (2014)

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
por: De Gregorio, Danilo, et al.
Publicado: (2021)

Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)
por: Kopra, Emma I, et al.
Publicado: (2022)

Safety Profile and Neurocognitive Function Following Acute 4-Fluoroamphetamine (4-FA) Administration in Humans
por: de Sousa Fernandes Perna, Elizabeth B., et al.
Publicado: (2018)

Self-inflicted neck wounds under influence of lysergic acid diethylamide: A case report and literature review
por: Le Daré, Brendan, et al.
Publicado: (2020)

A single dose of cocaine enhances prospective memory performance
por: Hutten, Nadia RPW, et al.
Publicado: (2018)

Optimized Analysis of Ergot Alkaloids in Rye Products by Liquid Chromatography-Fluorescence Detection Applying Lysergic Acid Diethylamide as an Internal Standard
por: Holderied, Iris, et al.
Publicado: (2019)

PM361. The hallucinogen D-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT(1A), D(2) and TAAR(1) receptors
por: Gregorio, Danilo De, et al.
Publicado: (2016)

A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence
por: Theunissen, Eef Lien, et al.
Publicado: (2022)

Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice
por: Inserra, Antonio, et al.
Publicado: (2021)

Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice
por: Elsilä, Lauri V, et al.
Publicado: (2022)

Lysergic acid diethylamide (LSD) promotes social behaviour through 5-HT(2A) and ampa in the medial prefrontal cortex (MPFC)
por: Markopoulos, A., et al.
Publicado: (2021)

Systems-level analysis of local field potentials reveals differential effects of lysergic acid diethylamide and ketamine on neuronal activity and functional connectivity
por: Nasretdinov, Azat, et al.
Publicado: (2023)

Acute Lysergic Acid Diethylamide Does Not Influence Reward-Driven Decision Making of C57BL/6 Mice in the Iowa Gambling Task
por: Elsilä, Lauri V., et al.
Publicado: (2020)

Identification of 1-Butyl-Lysergic Acid Diethylamide (1B-LSD) in Seized Blotter Paper Using an Integrated Workflow of Analytical Techniques and Chemo-Informatics
por: Tsochatzis, Emmanouil, et al.
Publicado: (2020)

Motives and Side-Effects of Microdosing With Psychedelics Among Users
por: Hutten, Nadia R P W, et al.
Publicado: (2019)

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
por: Hutten, Nadia R. P. W., et al.
Publicado: (2019)

Cytotoxic, genotoxic, and oxidative stress-related effects of lysergic acid diethylamide (LSD) and phencyclidine (PCP) in the human neuroblastoma SH-SY5Y cell line
por: Jurič, Andreja, et al.
Publicado: (2021)

Validation of a New Sensitive Method for the Detection and Quantification of R and S-Epimers of Ergot Alkaloids in Canadian Spring Wheat Utilizing Deuterated Lysergic Acid Diethylamide as an Internal Standard
por: Cherewyk, Jensen, et al.
Publicado: (2021)

Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies
por: Ramaekers, Johannes G., et al.
Publicado: (2022)

Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis
por: Theunissen, Eef L., et al.
Publicado: (2021)

Drug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamine
por: Kuypers, K. P. C., et al.
Publicado: (2018)

Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users
por: Mason, Natasha L., et al.
Publicado: (2019)

Valyl: Valerianic Acid Diethylamid
Publicado: (1902)

Cannot write session to /tmp/vufind_sessions/sess_bhbo7c9je8l86vt97po3m4iqs0